Latest Insider Transactions at Health Sciences Acquisitions Corp 2 (HSAQ)
This section provides a real-time view of insider transactions for Health Sciences Acquisitions Corp 2 (HSAQ). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Health Sciences Acquisitions Corp 2 to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Health Sciences Acquisitions Corp 2's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 12
2023
|
Eric S Fain Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,796
+15.15%
|
-
|
|
Apr 12
2023
|
Darren Sherman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,959
+15.15%
|
-
|
|
Apr 12
2023
|
David P Hochman Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
11,843
+15.15%
|
-
|
|
Apr 12
2023
|
David P Hochman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
29,551
+15.15%
|
-
|
|
Jan 30
2023
|
Medtronic PLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
6,835
+0.14%
|
$61,515
$9.28 P/Share
|
|
Jan 26
2023
|
Michael Kaswan Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
133,545
+50.0%
|
-
|
|
Jan 26
2023
|
Yuval Mika Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,720
+50.0%
|
-
|
|
Jan 26
2023
|
Jason Aryeh Director |
BUY
Grant, award, or other acquisition
|
Direct |
51,738
+50.0%
|
-
|
|
Jan 26
2023
|
Connealy Pamela Yanchik Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,488
+50.0%
|
-
|
|
Jan 26
2023
|
Darren Sherman Director |
BUY
Grant, award, or other acquisition
|
Direct |
68,189
+50.0%
|
-
|
|
Jan 26
2023
|
David P Hochman Director |
BUY
Grant, award, or other acquisition
|
Indirect |
54,482
+50.0%
|
-
|
|
Jan 26
2023
|
David P Hochman Director |
BUY
Grant, award, or other acquisition
|
Direct |
135,947
+50.0%
|
-
|
|
Jan 26
2023
|
Eric S Fain Director |
BUY
Grant, award, or other acquisition
|
Indirect |
22,065
+50.0%
|
-
|
|
Jan 26
2023
|
Rtw Investments, LP > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
2,310,000
+31.1%
|
-
|
|
Jan 26
2023
|
Geoffrey Wade Smith Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,507,166
+50.0%
|
-
|
|
Jan 26
2023
|
Geoffrey Wade Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,488
+50.0%
|
-
|
|
Jan 24
2023
|
Roderick Wong Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
1,808,512
+39.17%
|
$18,085,120
$10.0 P/Share
|
|
Jul 22
2022
|
Roderick Wong Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
1,000,000
+50.0%
|
$10,000,000
$10.01 P/Share
|